197 related articles for article (PubMed ID: 19743227)
1. Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers.
Sofuoglu M; Mitchell E; Mooney M
Hum Psychopharmacol; 2009 Oct; 24(7):559-64. PubMed ID: 19743227
[TBL] [Abstract][Full Text] [Related]
2. Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Sofuoglu M; Herman AI; Mooney M; Waters AJ
Psychopharmacology (Berl); 2009 Nov; 207(1):153-62. PubMed ID: 19693492
[TBL] [Abstract][Full Text] [Related]
3. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
Sofuoglu M; Herman AI; Li Y; Waters AJ
Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
[TBL] [Abstract][Full Text] [Related]
4. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers.
Sofuoglu M; Poling J; Mouratidis M; Kosten T
Psychopharmacology (Berl); 2006 Mar; 184(3-4):645-51. PubMed ID: 16432681
[TBL] [Abstract][Full Text] [Related]
5. Subjective responses to intravenous nicotine: greater sensitivity in women than in men.
Sofuoglu M; Mooney M
Exp Clin Psychopharmacol; 2009 Apr; 17(2):63-9. PubMed ID: 19331482
[TBL] [Abstract][Full Text] [Related]
6. Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence.
Novick AM; Duffy KA; Johnson RL; Sammel MD; Cao W; Strasser AA; Sofuoglu M; Kuzma A; Loughead J; Epperson CN
Nicotine Tob Res; 2022 Nov; 24(12):1898-1905. PubMed ID: 35713950
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
[TBL] [Abstract][Full Text] [Related]
8. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.
Myers CS; Taylor RC; Moolchan ET; Heishman SJ
Neuropsychopharmacology; 2008 Feb; 33(3):588-98. PubMed ID: 17443125
[TBL] [Abstract][Full Text] [Related]
9. Self-administration of intravenous nicotine in male and female cigarette smokers.
Sofuoglu M; Yoo S; Hill KP; Mooney M
Neuropsychopharmacology; 2008 Mar; 33(4):715-20. PubMed ID: 17534380
[TBL] [Abstract][Full Text] [Related]
10. Intravenous nicotine and caffeine: subjective and physiological effects in cocaine abusers.
Garrett BE; Griffiths RR
J Pharmacol Exp Ther; 2001 Feb; 296(2):486-94. PubMed ID: 11160635
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of nicotine delivery rate on subjective drug effects, urges to smoke, heart rate and blood pressure in tobacco smokers.
Jensen KP; Valentine G; Gueorguieva R; Sofuoglu M
Psychopharmacology (Berl); 2020 May; 237(5):1359-1369. PubMed ID: 31996940
[TBL] [Abstract][Full Text] [Related]
12. Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Saladin ME; McClure EA; Baker NL; Carpenter MJ; Ramakrishnan V; Hartwell KJ; Gray KM
Nicotine Tob Res; 2015 Apr; 17(4):398-406. PubMed ID: 25762749
[TBL] [Abstract][Full Text] [Related]
13. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
[TBL] [Abstract][Full Text] [Related]
14. Modafinil and nicotine interactions in abstinent smokers.
Sofuoglu M; Waters AJ; Mooney M
Hum Psychopharmacol; 2008 Jan; 23(1):21-30. PubMed ID: 17868195
[TBL] [Abstract][Full Text] [Related]
15. Threshold dose for intravenous nicotine self-administration in young adult non-dependent smokers.
MacLean RR; DeVito EE; Eid T; Parida S; Gueorguieva R; Sofuoglu M
Psychopharmacology (Berl); 2021 Aug; 238(8):2083-2090. PubMed ID: 33796907
[TBL] [Abstract][Full Text] [Related]
16. Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers.
Soria R; Stapleton JM; Gilson SF; Sampson-Cone A; Henningfield JE; London ED
Psychopharmacology (Berl); 1996 Dec; 128(3):221-6. PubMed ID: 8972541
[TBL] [Abstract][Full Text] [Related]
17. Transdermal nicotine maintenance attenuates the subjective and reinforcing effects of intravenous nicotine, but not cocaine or caffeine, in cigarette-smoking stimulant abusers.
Sobel BF; Sigmon SC; Griffiths RR
Neuropsychopharmacology; 2004 May; 29(5):991-1003. PubMed ID: 15010695
[TBL] [Abstract][Full Text] [Related]
18. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers.
Jones HE; Garrett BE; Griffiths RR
J Pharmacol Exp Ther; 1999 Jan; 288(1):188-97. PubMed ID: 9862770
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers.
Valentine GW; DeVito EE; Jatlow PI; Gueorguieva R; Sofuoglu M
J Psychopharmacol; 2018 Sep; 32(9):986-994. PubMed ID: 29788802
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking.
Rose JE; Behm FM; Westman EC
Pharmacol Biochem Behav; 2001 Feb; 68(2):187-97. PubMed ID: 11267622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
